GI
AMED

GAMMA Investing’s Amedisys AMED Stock Holding History

GAMMA Investing’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,512
Closed -$149K – 3851
2025
Q2 		$149K Buy
1,512
+1,475
+3,986% +$140K 0.01% 1118
2025
Q1 		$3.43K Sell
37
-58
-61% -$5.35K ﹤0.01% 3228
2024
Q4 		$8.63K Sell
95
-60
-39% -$5.51K ﹤0.01% 2692
2024
Q3 		$15K Buy
155
+152
+5,067% +$14.8K ﹤0.01% 2272
2024
Q2 		$275 Sell
3
-19
-86% -$1.76K ﹤0.01% 3285
2024
Q1 		$2.03K Sell
22
-5
-19% -$469 ﹤0.01% 2741
2023
Q4 		$2.54K Buy
+27
New +$2.52K ﹤0.01% 2499

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GAMMA Investing's AMED Position: Q3 2025 in Review

GAMMA Investing sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,512 shares — an estimated $149K sold.

GAMMA Investing first reported a position in AMED in Q4 2023 and held it in 7 quarters. The position peaked at $149K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • GAMMA Investing reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • GAMMA Investing sold 1,512 Amedisys shares in Q3 2025, an estimated $149K.
  • GAMMA Investing first reported a position in Amedisys in Q4 2023 and held it in 7 quarters.
  • GAMMA Investing's Amedisys position peaked at $149K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on GAMMA Investing's 13F filing for Q3 2025, filed 2 Oct 2025.